Spring 2022
Live Exhibitor Sessions
Date and Times:
Friday 6 May 2022
AM Break: 1000-1030 (PDT)
Lunch: 1200-1330 (PDT)
PM Break: 1500-1515 (PDT)
​
Raffle Instructions:
At Registration, attendees get a Exhibitor Booth "Passport". Make sure to write your name on your passport. For every exhibitor booth you attend you'll get a stamp. After you've filled your passport, drop it in the collection box at registration. During the PM break, we'll announce 3 raffle winners for a cash prize.
​​
1st Prize: $100 Gift Card
2nd & 3rd Prize: $50 Gift Card​
Endocrine Days Educational Institute gratefully acknowledges vendor financial support for our Endo Days Spring 2022 Program from the following companies:
Ultragenyx
Primary Rep: Susan Christopher
Sanofi
Primary Rep: Mike Quebedeaux
Recordati Rare Diseases
Primary Rep: Eric Hancock
Novo Nordisk Diabetes
Primary Rep: Sherrie Speller
Medtronic Diabetes
Primary Rep: Melissa Berendson
MannKind
Primary Rep: Paul Hanson
Janssen
Primary Rep: Jeremiah Colquitt
Horizon Therapeutics
Primary Rep: Chris Melton
Eli Lilly
Primary Rep: Jody Johnson
Dexcom
Primary Rep: Kim Morrison
Corcept
Primary Rep: Christina Byard
Boehringer-Ingelheim
Primary Rep: Angie Brosseau
Bayer Healthcare Pharmaceuticals
Primary Rep: Abner Manahan
AstraZeneca
Primary Rep: Derek Goff
Amryt Pharmaceuticals
Primary Rep: Robin Mergen
Alto Pharmacy
Primary Rep: Julie Cyr
Abbott
Primary Rep: Frank Iacolucci
For CME:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Washington State Medical Association and the Endocrine Days Educational Institute. The WSMA is accredited by the ACCME to provide continuing medical education for physicians.
The WSMA designates this Other activity (blended live course and enduring material) for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to 6 hour(s) of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
For MOC:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
​
Planners: The following planners have indicated (a) relevant financial relationship(s) with an ACCME-defined ineligible company:
Savitha Subramanian, Abbott Diabetes Care, advisory board member; Amarin, advisory board member. Kristina Utzschneider, Nevro, consultant; Clinical Care Options, speaker.
All relevant financial relationships have been mitigated. All others in control of content have indicated no relevant financial relationship with an ACCME-defined ineligible company. All clinical content presented will be evidence-based and unbiased.
​
Faculty: The following faculty have indicated (a) relevant financial relationship(s) with an ACCME-defined ineligible company:
Katherine Tuttle, Eli Lilly & Company, consultant, speaker; Boehringer Ingelheim, consultant; AstraZeneca, consultant, speaker; Gilead, consultant, speaker; Goldfinch Bio, consultant, speaker, researcher; Novo Nordisk, consultant, speaker; Bayer, speaker, researcher; Travere, consultant, researcher.
All relevant financial relationships have been mitigated. All others in control of content have indicated no relevant financial relationship with an ACCME-defined ineligible company. All clinical content presented will be evidence-based and unbiased.